Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4UED

Complex of human eIF4E with the 4E binding protein 4E-BP1

Summary for 4UED
Entry DOI10.2210/pdb4ued/pdb
Related4UE8 4UE9 4UEA 4UEB 4UEC
DescriptorEUKARYOTIC TRANSLATION INITIATION FACTOR 4E, EUKARYOTIC TRANSLATION FACTOR 4E-BINDING PROTEIN 1 (3 entities in total)
Functional Keywordstranslation, gene regulation, cap binding protein, 4e binding protein, translational repression
Biological sourceHOMO SAPIENS (HUMAN)
More
Cellular locationCytoplasm, P-body : P06730
Total number of polymer chains2
Total formula weight25990.71
Authors
Peter, D.,Weichenrieder, O. (deposition date: 2014-12-16, release date: 2015-02-25, Last modification date: 2023-12-20)
Primary citationPeter, D.,Igreja, C.,Weber, R.,Wohlbold, L.,Weiler, C.,Ebertsch, L.,Weichenrieder, O.,Izaurralde, E.
Molecular Architecture of 4E-BP Translational Inhibitors Bound to Eif4E.
Mol.Cell, 57:1074-, 2015
Cited by
PubMed Abstract: The eIF4E-binding proteins (4E-BPs) represent a diverse class of translation inhibitors that are often deregulated in cancer cells. 4E-BPs inhibit translation by competing with eIF4G for binding to eIF4E through an interface that consists of canonical and non-canonical eIF4E-binding motifs connected by a linker. The lack of high-resolution structures including the linkers, which contain phosphorylation sites, limits our understanding of how phosphorylation inhibits complex formation. Furthermore, the binding mechanism of the non-canonical motifs is poorly understood. Here, we present structures of human eIF4E bound to 4E-BP1 and fly eIF4E bound to Thor, 4E-T, and eIF4G. These structures reveal architectural elements that are unique to 4E-BPs and provide insight into the consequences of phosphorylation. Guided by these structures, we designed and crystallized a 4E-BP mimic that shows increased repressive activity. Our studies pave the way for the rational design of 4E-BP mimics as therapeutic tools to decrease translation during oncogenic transformation.
PubMed: 25702871
DOI: 10.1016/J.MOLCEL.2015.01.017
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon